IOA-289, a Novel, Clinical Stage Autotaxin Inhibitor for the Treatment of Fibrotic Lung Disease

Autor: M. Deken, K. Niewola-Staszkowska, M.M. Lahn, A. Cheasty, P. Shah, S. Farrow, L. van der Veen, Z. Johnson
Rok vydání: 2021
Zdroj: TP5. TP005 INTERSTITIAL LUNG DISEASE PATHOGENESIS.
DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1332
Databáze: OpenAIRE